#United States #healthcare technology #Tampa #Coalesce Capital #DAS Health

Coalesce Capital Acquires DAS Health

In a strategic move that marks a significant expansion in the healthcare technology sector, Coalesce Capital has officially announced the acquisition of a majority stake in DAS Health, a renowned provider of healthcare IT and business solutions. This acquisition was revealed on May 27, 2025, in a joint statement from both companies, highlighting their commitment to enhancing the efficiency of healthcare organizations across North America.

DAS Health, headquartered in Tampa, Florida, has established itself as a pivotal player in healthcare IT, delivering a wide array of services, including managed IT, cybersecurity, and revenue cycle management. Their solutions are designed to streamline workflows and enhance productivity, thereby improving patient care outcomes across thousands of healthcare organizations.

With the acquisition, Coalesce Capital aims to further bolster DAS Health’s capabilities through strategic investments in technology and talent. The firm recognizes the increasing demands on healthcare providers, particularly in areas such as patient data management and regulatory compliance. By enhancing DAS Health’s offerings, Coalesce is setting the stage for the company to expand its reach and better support healthcare providers in overcoming these challenges.

In a statement, Michelle Jaeger, the President and CEO of DAS Health, expressed enthusiasm about the partnership. She noted, "We are thrilled to welcome Coalesce Capital as we embark on this next chapter for DAS Health. Their investment underscores our commitment to delivering innovative solutions that help healthcare organizations operate more efficiently and improve patient care. With Sheridan's continued support, we are well-positioned to broaden our reach and help even more providers achieve operational excellence and better outcomes."

The collaboration is particularly timely as the healthcare sector faces significant technological transitions. Coalesce Capital’s founder and managing partner, Stephanie Geveda, commented on the urgency and importance of DAS Health’s solutions, stating, "As healthcare organizations face growing challenges in patient data management, regulatory compliance, and operational demands, DAS Health stands out as a trusted partner solving these critical pain points. We are excited to invest in DAS Health, whose proven track record for delivering reliable, mission-critical solutions has already improved care for over 15 million patients."

Moreover, the acquisition is not only a win for Coalesce and DAS Health but also reflects the overarching trend of private equity investment in the healthcare sector. Jonathan Lewis, a Partner at Sheridan Capital Partners, noted the ongoing expansion of DAS Health's solutions since their initial investment in 2021, recognizing the progress made under the leadership of the DAS Health team.

The financial intricacies of this transaction have not been disclosed in detail, but it is evident that such partnerships are increasingly pivotal in shaping the future of healthcare technology.

As both companies move forward, DAS Health is expected to continue enhancing its offerings while also pursuing strategic acquisitions, further leading the way in improving operational efficiency for healthcare providers. The ongoing support from Sheridan Capital, which retains a minority ownership position, will undoubtedly play a crucial role in driving this growth.

In conclusion, this acquisition by Coalesce Capital positions DAS Health for an exciting future as they continue to provide essential services that address the complex needs of healthcare organizations. With over 15 million patients already benefiting from their innovative solutions, this partnership marks a critical step in advancing the healthcare IT landscape and meeting the evolving demands of this essential industry.